Background: Totally implantable venous access ports (“ports”) are a cornerstone of the treatment and survival of highly vulnerable patients, particularly those requiring chemotherapy for cancer. Because they are a lifeline for such patients, the ability to use ports for indications other than their primary use (e.g., chemotherapy) is often restricted. We sought to describe current [...]